Human Immune Globulin (HCPCS/CPT 90281-90284) reimbursement classification
This document lists specific human immune globulin drugs by CPT/HCPCS codes 90281-90284 and indicates whether they are covered as self-administered or provider-administered; it applies to Florida Blue payment/reimbursement determinations and informs providers/members about coverage variability.
No material clinical or coverage changes in this revision.
Coverage Designation for Human Immune Globulin Products
Coverage status
Coverage designation for the listed human immune globulin products:
ALL of the following
HCPCS/CPT code 90281
- 90281 — GamaSTAN S/D; HUMAN IMMUNE GLOBULIN: Covered as Self-Administered or Provider Administered where specified in benefit details.
HCPCS/CPT code 90283
- 90283 — CARIMUNE NF; FLEBOGAMMA; FLEBOGAMMA DIF; GAMMAGARD; GAMMAGARD SD; GAMMAKED; GAMMAPLEX; GAMUNEX; GAMUNEX-C; OCTAGAM; PRIVIGEN; and other listed HUMAN IMMUNE GLOBULIN products: Covered as Self-Administered or Provider Administered where specified in benefit details.
HCPCS/CPT code 90284
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.